Histone Deacetylases as Targets for Melanoma Immunotherapy
Cancer represents the second leading cause of death in the United States. For many malignancies, currently available treatment options offer little long-lasting survival benefits to patients. However, recent studies have shown immunotherapeutic approaches to be an attractive strategy to cancer treat...
Main Author: | |
---|---|
Format: | Others |
Published: |
Scholar Commons
2013
|
Subjects: | |
Online Access: | http://scholarcommons.usf.edu/etd/4856 http://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=6052&context=etd |